The Global Animal Health Active Pharmaceutical Ingredients market is expected to be around US$ 249 Billion by 2028 at a CAGR of 6.7% in the given forecast period.
Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth.
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active.
The global Animal Health Active Pharmaceutical Ingredients market is segregated on the basis of Application as Pharmacy, Pet Hospital, and Other. Based on Type the global Animal Health Active Pharmaceutical Ingredients market is segmented in Antiparasitics, Anti-infectives, NSAIDs & Anesthetics, and Others.
The global Animal Health Active Pharmaceutical Ingredients market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Animal Health Active Pharmaceutical Ingredients market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Glenmark Pharmaceutical, Zoetis, Eli Lilly, Sanofi Winthrop Industrie, Indukern, Ofichem, P&R SpA (Olon SpA), Lonza Group, Huvepharma, Sequent Scientific, and others are among the major players in the global Animal Health Active Pharmaceutical Ingredients market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Animal Health Active Pharmaceutical Ingredients Market has been segmented as below:
Animal Health Active Pharmaceutical Ingredients Market, By Application
Animal Health Active Pharmaceutical Ingredients Market, By Type
Animal Health Active Pharmaceutical Ingredients Market, By Region
Animal Health Active Pharmaceutical Ingredients Market, By Company
The report covers:
Report Scope:
The global Animal Health Active Pharmaceutical Ingredients market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Animal Health Active Pharmaceutical Ingredients market share. Major industry players with significant revenue share include Glenmark Pharmaceutical, Zoetis, Eli Lilly, Sanofi Winthrop Industrie, Indukern, Ofichem, P&R SpA (Olon SpA), Lonza Group, Huvepharma, Sequent Scientific, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Traveler’s Diarrhea Therapeutics Market
Elderly and Disabled Assistive Devices Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Animal Health Active Pharmaceutical Ingredients Market, By Application
5.1 Introduction
5.2 Pharmacy
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Pet Hospital
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Animal Health Active Pharmaceutical Ingredients Market, By Type
6.1 Introduction
6.2 Antiparasitics
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Anti-infectives
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 NSAIDs & Anesthetics
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Others
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Animal Health Active Pharmaceutical Ingredients Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Animal Health Active Pharmaceutical Ingredients, By Application
7.2.2 North America Animal Health Active Pharmaceutical Ingredients, By Type
7.3 Europe
7.3.1 Europe Animal Health Active Pharmaceutical Ingredients, By Application
7.3.2 Europe Animal Health Active Pharmaceutical Ingredients, By Type
7.4 Asia-Pacific
7.4.1 Asia-Pacific Animal Health Active Pharmaceutical Ingredients, By Application
7.4.2 Asia-Pacific Animal Health Active Pharmaceutical Ingredients, By Type
7.5 Rest of the World
7.5.1 Rest of the World Animal Health Active Pharmaceutical Ingredients, By Application
7.5.2 Rest of the World Animal Health Active Pharmaceutical Ingredients, By Type
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Glenmark Pharmaceutical
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Zoetis
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Eli Lilly
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Sanofi Winthrop Industrie
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Indukern
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Ofichem
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 P&R SpA (Olon SpA)
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Lonza Group
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Huvepharma
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Sequent Scientific
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Animal Health Active Pharmaceutical Ingredients Market has been segmented as below:
Animal Health Active Pharmaceutical Ingredients Market, By Application
Animal Health Active Pharmaceutical Ingredients Market, By Type
Animal Health Active Pharmaceutical Ingredients Market, By Region
Animal Health Active Pharmaceutical Ingredients Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
